Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apyx Medical Corporation (APYX)
NASDAQ:APYX
Holding APYX?
Track your performance easily
APYX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.97 - $4.53
Previous Close$1.3
Volume24.90K
Average Volume (3M)36.01K
Market Cap
$45.04M
Enterprise Value$51.24M
Total Cash (Recent Filing)$32.68M
Total Debt (Recent Filing)$38.70M
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Nov 07, 2024EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.82
Shares Outstanding34,643,926
10 Day Avg. Volume16,784
30 Day Avg. Volume36,012
Standard Deviation0.26
R-Squared0.06
Alpha-0.00783
Financial Highlights & Ratios
Price to Book (P/B)3.05
Price to Sales (P/S)0.92
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.04
Enterprise Value/Gross Profit1.52
Enterprise Value/Ebitda-2.19
Forecast
1Y Price Target
$2.25Price Target Upside73.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Apyx Medical News
PremiumCompany Announcements
Apyx Medical Announces Boardroom Overhaul and New Chairman
PremiumPre-Earnings
Is APYX a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Market PotentialRenuvion is highlighted as a differentiated helium-based plasma technology with potential in high-growth plastic surgery markets.
Sales GrowthOEM sales were $2.8 mln (+14% y/y), demonstrating growth in the original equipment manufacturing division.
Technology DifferentiationRenuvion is a differentiated helium-based plasma technology with specific labels that could distinguish it from competitive options over time.
Bears Say
Financial PerformanceTotal sales came in at $10.2 mln (-16% y/y), indicating a decline in year-over-year revenue.
GuidanceInitial 2024 sales guidance came in well below consensus, as management applied a more cautious near-term view.
Sales PerformanceAdvanced Energy (AE) sales were $7.5 mln (-23% y/y), showing a significant decrease in a key segment.
---
Ownership Overview
28.60% Insiders
11.76% Mutual Funds
30.15% Other Institutional Investors
29.49% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
APYX FAQ
What was Apyx Medical Corporation’s price range in the past 12 months?
Apyx Medical Corporation lowest stock price was $0.97 and its highest was $4.53 in the past 12 months.
What is Apyx Medical Corporation’s market cap?
Currently, no data Available
When is Apyx Medical Corporation’s upcoming earnings report date?
Apyx Medical Corporation’s upcoming earnings report date is Nov 07, 2024 which is in 60 days.
How were Apyx Medical Corporation’s earnings last quarter?
Apyx Medical Corporation released its earnings results on Aug 08, 2024. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.198 by $0.008.
Is Apyx Medical Corporation overvalued?
According to Wall Street analysts Apyx Medical Corporation’s price is currently Undervalued.
Does Apyx Medical Corporation pay dividends?
Apyx Medical Corporation does not currently pay dividends.
What is Apyx Medical Corporation’s EPS estimate?
Apyx Medical Corporation’s EPS estimate is -$0.18.
How many shares outstanding does Apyx Medical Corporation have?
Apyx Medical Corporation has 34,643,925 shares outstanding.
What happened to Apyx Medical Corporation’s price movement after its last earnings report?
Apyx Medical Corporation reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.198. Following the earnings report the stock price went up 1.961%.
Which hedge fund is a major shareholder of Apyx Medical Corporation?
Among the largest hedge funds holding Apyx Medical Corporation’s share is Royce & Associates LLC. It holds Apyx Medical Corporation’s shares valued at 3M.
---
Apyx Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.25 (73.08% Upside)
$2.25 (73.08% Upside)
Hedge Fund Trend
Increased
By 60.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $6.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.63%
12-Months-Change
Fundamentals
Return on Equity
-110.50%
Trailing 12-Months
Asset Growth
4.75%
Trailing 12-Months
Company Description
Apyx Medical Corporation
Apyx Medical Corp. operates as an energy-based medical technology company. It engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
---
APYX Earnings Call
Q2 2024
0:00 / 0:00
---
APYX Stock 12 Month Forecast
Average Price Target
$2.25
▲(73.08% Upside)
Technical Analysis
Best Analysts Covering APYX
1 Year
1 Year Success Rate
4/23 ratings generated profit
1 Year Average Return
-31.21%
reiterated a buy rating last month
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 17.39% of your transactions generating a profit, with an average return of -31.21% per trade.
---